Labcyte Reaches Agreement With Merck to Supply Acoustic-Mass Spectrometry Equipment
April 17, 2018 04:30 AM Pacific Daylight Time SAN JOSE, Calif.–(BUSINESS WIRE)–Labcyte Inc. announced today that the company has entered an agreement with Merck, known as MSD outside the United States and Canada, to utilize Acoustic-Mass Spectrometry (Acoustic-MS) in drug discovery and development. Pioneered by Labcyte, acoustic droplet ejection (ADE) technology uses the gentle energy... Read more